MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.180
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
MacroGenics Employees
MacroGenics had 339 employees as of December 31, 2023. The number of employees decreased by 18 or -5.04% compared to the previous year.
Employees
339
Change (1Y)
-18
Growth (1Y)
-5.04%
Revenue / Employee
$416,900
Profits / Employee
-$287,956
Market Cap
199.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inogen | 834 |
Biodesix | 217 |
Inhibrx Biosciences | 172 |
Inventiva | 123 |
Atai Life Sciences | 83 |
XBiotech | 82 |
Verastem | 73 |
Lexeo Therapeutics | 58 |
MGNX News
- 19 days ago - MacroGenics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 6 weeks ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - MacroGenics Announces Leadership Transition - GlobeNewsWire
- 7 weeks ago - MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 2 months ago - Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders - Accesswire
- 2 months ago - MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA® - Business Wire